Ardelyx to Participate in Three Upcoming Investor Conferences in September
FREMONT, Calif., Sept. 8, 2020 /PRNewswire/ --Ardelyx Inc.. (Nasdaq: ARDX), a biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today announced that Ardelyx management will participate in three upcoming investor conferences in September including:
Both the H.C. Wainwright and Cantor Fitzgerald conference presentations will be available via webcast. To access the live webcasts of Ardelyx's presentations, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcasts will be available on the Ardelyx website for 30 days following each conference.
About Ardelyx, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ardelyx-to-participate-in-three-upcoming-investor-conferences-in-september-301124705.html
Company Codes: NASDAQ-NMS:ARDX